Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can have difficulty in moving. Due to hypersomnia patients may have restlessness, loss of appetite hallucinations and slow speech.

Market Analysis and Insights: Global Hypersomnia Drug Market

The global Hypersomnia Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Hypersomnia Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Hypersomnia Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hypersomnia Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hypersomnia Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hypersomnia Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hypersomnia Drug revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Hypersomnia Drug Market Report

Report Metric	Details
Report Name	Hypersomnia Drug Market
CAGR	5%
Segment by Type	Provigil Xyrem Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Jazz Pharmaceuticals, BIOPROJET, AVADEL PHARMACEUTICALS, GlaxoSmithKline, Pfizer, Theranexus, Fisher & Paykel Healthcare, Drive Medical, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Hypersomnia Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hypersomnia Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hypersomnia Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Hypersomnia Drug Market report?

Ans: The main players in the Hypersomnia Drug Market are Teva, Jazz Pharmaceuticals, BIOPROJET, AVADEL PHARMACEUTICALS, GlaxoSmithKline, Pfizer, Theranexus, Fisher & Paykel Healthcare, Drive Medical, Merck

What are the Application segmentation covered in the Hypersomnia Drug Market report?

Ans: The Applications covered in the Hypersomnia Drug Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Hypersomnia Drug Market report?

Ans: The Types covered in the Hypersomnia Drug Market report are Provigil, Xyrem, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hypersomnia Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Provigil

1.2.3 Xyrem

1.2.4 Others

1.3 Market by Application

1.3.1 Global Hypersomnia Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hypersomnia Drug Market Perspective (2019-2030)

2.2 Global Hypersomnia Drug Growth Trends by Region

2.2.1 Hypersomnia Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Hypersomnia Drug Historic Market Size by Region (2019-2024)

2.2.3 Hypersomnia Drug Forecasted Market Size by Region (2025-2030)

2.3 Hypersomnia Drug Market Dynamics

2.3.1 Hypersomnia Drug Industry Trends

2.3.2 Hypersomnia Drug Market Drivers

2.3.3 Hypersomnia Drug Market Challenges

2.3.4 Hypersomnia Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Hypersomnia Drug by Players

3.1.1 Global Hypersomnia Drug Revenue by Players (2019-2024)

3.1.2 Global Hypersomnia Drug Revenue Market Share by Players (2019-2024)

3.2 Global Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Hypersomnia Drug, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Hypersomnia Drug Market Concentration Ratio

3.4.1 Global Hypersomnia Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hypersomnia Drug Revenue in 2023

3.5 Global Key Players of Hypersomnia Drug Head office and Area Served

3.6 Global Key Players of Hypersomnia Drug, Product and Application

3.7 Global Key Players of Hypersomnia Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hypersomnia Drug Breakdown Data by Type

4.1 Global Hypersomnia Drug Historic Market Size by Type (2019-2024)

4.2 Global Hypersomnia Drug Forecasted Market Size by Type (2025-2030)

5 Hypersomnia Drug Breakdown Data by Application

5.1 Global Hypersomnia Drug Historic Market Size by Application (2019-2024)

5.2 Global Hypersomnia Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hypersomnia Drug Market Size (2019-2030)

6.2 North America Hypersomnia Drug Market Size by Type

6.2.1 North America Hypersomnia Drug Market Size by Type (2019-2024)

6.2.2 North America Hypersomnia Drug Market Size by Type (2025-2030)

6.2.3 North America Hypersomnia Drug Market Share by Type (2019-2030)

6.3 North America Hypersomnia Drug Market Size by Application

6.3.1 North America Hypersomnia Drug Market Size by Application (2019-2024)

6.3.2 North America Hypersomnia Drug Market Size by Application (2025-2030)

6.3.3 North America Hypersomnia Drug Market Share by Application (2019-2030)

6.4 North America Hypersomnia Drug Market Size by Country

6.4.1 North America Hypersomnia Drug Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Hypersomnia Drug Market Size by Country (2019-2024)

6.4.3 North America Hypersomnia Drug Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Hypersomnia Drug Market Size (2019-2030)

7.2 Europe Hypersomnia Drug Market Size by Type

7.2.1 Europe Hypersomnia Drug Market Size by Type (2019-2024)

7.2.2 Europe Hypersomnia Drug Market Size by Type (2025-2030)

7.2.3 Europe Hypersomnia Drug Market Share by Type (2019-2030)

7.3 Europe Hypersomnia Drug Market Size by Application

7.3.1 Europe Hypersomnia Drug Market Size by Application (2019-2024)

7.3.2 Europe Hypersomnia Drug Market Size by Application (2025-2030)

7.3.3 Europe Hypersomnia Drug Market Share by Application (2019-2030)

7.4 Europe Hypersomnia Drug Market Size by Country

7.4.1 Europe Hypersomnia Drug Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Hypersomnia Drug Market Size by Country (2019-2024)

7.4.3 Europe Hypersomnia Drug Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Hypersomnia Drug Market Size (2019-2030)

8.2 China Hypersomnia Drug Market Size by Type

8.2.1 China Hypersomnia Drug Market Size by Type (2019-2024)

8.2.2 China Hypersomnia Drug Market Size by Type (2025-2030)

8.2.3 China Hypersomnia Drug Market Share by Type (2019-2030)

8.3 China Hypersomnia Drug Market Size by Application

8.3.1 China Hypersomnia Drug Market Size by Application (2019-2024)

8.3.2 China Hypersomnia Drug Market Size by Application (2025-2030)

8.3.3 China Hypersomnia Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Hypersomnia Drug Market Size (2019-2030)

9.2 Asia Hypersomnia Drug Market Size by Type

9.2.1 Asia Hypersomnia Drug Market Size by Type (2019-2024)

9.2.2 Asia Hypersomnia Drug Market Size by Type (2025-2030)

9.2.3 Asia Hypersomnia Drug Market Share by Type (2019-2030)

9.3 Asia Hypersomnia Drug Market Size by Application

9.3.1 Asia Hypersomnia Drug Market Size by Application (2019-2024)

9.3.2 Asia Hypersomnia Drug Market Size by Application (2025-2030)

9.3.3 Asia Hypersomnia Drug Market Share by Application (2019-2030)

9.4 Asia Hypersomnia Drug Market Size by Region

9.4.1 Asia Hypersomnia Drug Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Hypersomnia Drug Market Size by Region (2019-2024)

9.4.3 Asia Hypersomnia Drug Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Hypersomnia Drug Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Type

10.2.1 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Hypersomnia Drug Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Application

10.3.1 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Hypersomnia Drug Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Country

10.4.1 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Details

11.1.2 Teva Business Overview

11.1.3 Teva Hypersomnia Drug Introduction

11.1.4 Teva Revenue in Hypersomnia Drug Business (2019-2024)

11.1.5 Teva Recent Developments

11.2 Jazz Pharmaceuticals

11.2.1 Jazz Pharmaceuticals Company Details

11.2.2 Jazz Pharmaceuticals Business Overview

11.2.3 Jazz Pharmaceuticals Hypersomnia Drug Introduction

11.2.4 Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2019-2024)

11.2.5 Jazz Pharmaceuticals Recent Developments

11.3 BIOPROJET

11.3.1 BIOPROJET Company Details

11.3.2 BIOPROJET Business Overview

11.3.3 BIOPROJET Hypersomnia Drug Introduction

11.3.4 BIOPROJET Revenue in Hypersomnia Drug Business (2019-2024)

11.3.5 BIOPROJET Recent Developments

11.4 AVADEL PHARMACEUTICALS

11.4.1 AVADEL PHARMACEUTICALS Company Details

11.4.2 AVADEL PHARMACEUTICALS Business Overview

11.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Introduction

11.4.4 AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2019-2024)

11.4.5 AVADEL PHARMACEUTICALS Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Hypersomnia Drug Introduction

11.5.4 GlaxoSmithKline Revenue in Hypersomnia Drug Business (2019-2024)

11.5.5 GlaxoSmithKline Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Hypersomnia Drug Introduction

11.6.4 Pfizer Revenue in Hypersomnia Drug Business (2019-2024)

11.6.5 Pfizer Recent Developments

11.7 Theranexus

11.7.1 Theranexus Company Details

11.7.2 Theranexus Business Overview

11.7.3 Theranexus Hypersomnia Drug Introduction

11.7.4 Theranexus Revenue in Hypersomnia Drug Business (2019-2024)

11.7.5 Theranexus Recent Developments

11.8 Fisher & Paykel Healthcare

11.8.1 Fisher & Paykel Healthcare Company Details

11.8.2 Fisher & Paykel Healthcare Business Overview

11.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Introduction

11.8.4 Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2019-2024)

11.8.5 Fisher & Paykel Healthcare Recent Developments

11.9 Drive Medical

11.9.1 Drive Medical Company Details

11.9.2 Drive Medical Business Overview

11.9.3 Drive Medical Hypersomnia Drug Introduction

11.9.4 Drive Medical Revenue in Hypersomnia Drug Business (2019-2024)

11.9.5 Drive Medical Recent Developments

11.10 Merck

11.10.1 Merck Company Details

11.10.2 Merck Business Overview

11.10.3 Merck Hypersomnia Drug Introduction

11.10.4 Merck Revenue in Hypersomnia Drug Business (2019-2024)

11.10.5 Merck Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

TEVA

Jazz Pharmaceuticals

Bioprojet

Avadel Pharmaceuticals

GlaxoSmithKline PLC

Pfizer Inc

Theranexus

Fisher & Paykel Healthcare

Drive Medical

Merck

List of Tables

Table 1. Global Hypersomnia Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Provigil

Table 3. Key Players of Xyrem

Table 4. Key Players of Others

Table 5. Global Hypersomnia Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Hypersomnia Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Hypersomnia Drug Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Hypersomnia Drug Market Share by Region (2019-2024)

Table 9. Global Hypersomnia Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Hypersomnia Drug Market Share by Region (2025-2030)

Table 11. Hypersomnia Drug Market Trends

Table 12. Hypersomnia Drug Market Drivers

Table 13. Hypersomnia Drug Market Challenges

Table 14. Hypersomnia Drug Market Restraints

Table 15. Global Hypersomnia Drug Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Hypersomnia Drug Revenue Share by Players (2019-2024)

Table 17. Global Top Hypersomnia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2023)

Table 18. Global Hypersomnia Drug Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Hypersomnia Drug Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Hypersomnia Drug, Headquarters and Area Served

Table 21. Global Key Players of Hypersomnia Drug, Product and Application

Table 22. Global Key Players of Hypersomnia Drug, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Hypersomnia Drug Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Hypersomnia Drug Revenue Market Share by Type (2019-2024)

Table 26. Global Hypersomnia Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Hypersomnia Drug Revenue Market Share by Type (2025-2030)

Table 28. Global Hypersomnia Drug Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Hypersomnia Drug Revenue Share by Application (2019-2024)

Table 30. Global Hypersomnia Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Hypersomnia Drug Revenue Share by Application (2025-2030)

Table 32. North America Hypersomnia Drug Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Hypersomnia Drug Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Hypersomnia Drug Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Hypersomnia Drug Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Hypersomnia Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Hypersomnia Drug Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Hypersomnia Drug Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Hypersomnia Drug Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Hypersomnia Drug Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Hypersomnia Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Hypersomnia Drug Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Hypersomnia Drug Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Hypersomnia Drug Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Hypersomnia Drug Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Hypersomnia Drug Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Hypersomnia Drug Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Hypersomnia Drug Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Hypersomnia Drug Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Hypersomnia Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Hypersomnia Drug Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Hypersomnia Drug Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Hypersomnia Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million)

Table 64. Teva Company Details

Table 65. Teva Business Overview

Table 66. Teva Hypersomnia Drug Product

Table 67. Teva Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 68. Teva Recent Developments

Table 69. Jazz Pharmaceuticals Company Details

Table 70. Jazz Pharmaceuticals Business Overview

Table 71. Jazz Pharmaceuticals Hypersomnia Drug Product

Table 72. Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 73. Jazz Pharmaceuticals Recent Developments

Table 74. BIOPROJET Company Details

Table 75. BIOPROJET Business Overview

Table 76. BIOPROJET Hypersomnia Drug Product

Table 77. BIOPROJET Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 78. BIOPROJET Recent Developments

Table 79. AVADEL PHARMACEUTICALS Company Details

Table 80. AVADEL PHARMACEUTICALS Business Overview

Table 81. AVADEL PHARMACEUTICALS Hypersomnia Drug Product

Table 82. AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 83. AVADEL PHARMACEUTICALS Recent Developments

Table 84. GlaxoSmithKline Company Details

Table 85. GlaxoSmithKline Business Overview

Table 86. GlaxoSmithKline Hypersomnia Drug Product

Table 87. GlaxoSmithKline Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 88. GlaxoSmithKline Recent Developments

Table 89. Pfizer Company Details

Table 90. Pfizer Business Overview

Table 91. Pfizer Hypersomnia Drug Product

Table 92. Pfizer Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 93. Pfizer Recent Developments

Table 94. Theranexus Company Details

Table 95. Theranexus Business Overview

Table 96. Theranexus Hypersomnia Drug Product

Table 97. Theranexus Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 98. Theranexus Recent Developments

Table 99. Fisher & Paykel Healthcare Company Details

Table 100. Fisher & Paykel Healthcare Business Overview

Table 101. Fisher & Paykel Healthcare Hypersomnia Drug Product

Table 102. Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 103. Fisher & Paykel Healthcare Recent Developments

Table 104. Drive Medical Company Details

Table 105. Drive Medical Business Overview

Table 106. Drive Medical Hypersomnia Drug Product

Table 107. Drive Medical Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 108. Drive Medical Recent Developments

Table 109. Merck Company Details

Table 110. Merck Business Overview

Table 111. Merck Hypersomnia Drug Product

Table 112. Merck Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million)

Table 113. Merck Recent Developments

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hypersomnia Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Hypersomnia Drug Market Share by Type: 2023 VS 2030

Figure 3. Provigil Features

Figure 4. Xyrem Features

Figure 5. Others Features

Figure 6. Global Hypersomnia Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Hypersomnia Drug Market Share by Application: 2023 VS 2030

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Hypersomnia Drug Report Years Considered

Figure 12. Global Hypersomnia Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Hypersomnia Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Hypersomnia Drug Market Share by Region: 2023 VS 2030

Figure 15. Global Hypersomnia Drug Market Share by Players in 2023

Figure 16. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Hypersomnia Drug Revenue in 2023

Figure 18. North America Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Hypersomnia Drug Market Share by Type (2019-2030)

Figure 20. North America Hypersomnia Drug Market Share by Application (2019-2030)

Figure 21. North America Hypersomnia Drug Market Share by Country (2019-2030)

Figure 22. United States Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Hypersomnia Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Hypersomnia Drug Market Share by Type (2019-2030)

Figure 26. Europe Hypersomnia Drug Market Share by Application (2019-2030)

Figure 27. Europe Hypersomnia Drug Market Share by Country (2019-2030)

Figure 28. Germany Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Hypersomnia Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Hypersomnia Drug Market Share by Type (2019-2030)

Figure 36. China Hypersomnia Drug Market Share by Application (2019-2030)

Figure 37. Asia Hypersomnia Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Hypersomnia Drug Market Share by Type (2019-2030)

Figure 39. Asia Hypersomnia Drug Market Share by Application (2019-2030)

Figure 40. Asia Hypersomnia Drug Market Share by Region (2019-2030)

Figure 41. Japan Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Hypersomnia Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Hypersomnia Drug Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Hypersomnia Drug Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Hypersomnia Drug Market Share by Country (2019-2030)

Figure 51. Brazil Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Teva Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 58. Jazz Pharmaceuticals Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 59. BIOPROJET Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 60. AVADEL PHARMACEUTICALS Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 61. GlaxoSmithKline Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 62. Pfizer Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 63. Theranexus Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 64. Fisher & Paykel Healthcare Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 65. Drive Medical Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 66. Merck Revenue Growth Rate in Hypersomnia Drug Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Global Insomnia Treatment Drugs Market Insights Forecast to 2030

Global Narcolepsy Treatment Market Research Report 2024

Global Circadian Rhythm Sleep Disorders Market Insights Forecast to 2030

Global Insomnia Monitoring Equipment Market Insights Forecast to 2030

Global Anti snoring Treatment Market Insights Forecast to 2030

Narcolepsy Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insomnia Therapy Market Research Report 2025

Short Sleep Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Fatigue Syndrome Treatment Market Insights Forecast to 2030

Global Menopause Drugs Market Insights Forecast to 2030

Global Circadian Rhythm Sleep Disorders Drug Market Research Report 2025

Global Jet Lag Therapy Pharmaceuticals Market Insights Forecast to 2030

Global Sleep Disorder Therapies Market Research Report 2024

Global Sleep Apnea Therapies Market Insights Forecast to 2030

Global Antidepressants Drugs Market Insights Forecast to 2030

Global Obsessive Compulsive Disorder Drugs Market Insights Forecast to 2030

Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2030

Global Jet Lag Treatment Market Insights Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-5H251

Thu Jun 05 00:00:00 UTC 2025

Add to Cart

Global Melatonin Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23J15873

Tue Jun 03 00:00:00 UTC 2025

Add to Cart

Global Melatonin Receptor Agonists Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12L14987

Fri May 30 00:00:00 UTC 2025

Add to Cart

Global Sleep Apnea Diagnostic and Therapeutic Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-15F12960

Thu May 29 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Hypersomnia Drug Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-25P5794

Global Hypersomnia Drug Market Insights, Forecast to 2030

FEATURED COMPANIES

Hypersomnia Drug Market Size

Hypersomnia Drug Market

Scope of Hypersomnia Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Hypersomnia Drug Market report?

What are the Application segmentation covered in the Hypersomnia Drug Market report?

What are the Type segmentation covered in the Hypersomnia Drug Market report?

FEATURED COMPANIES

RELATED REPORTS